| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |